Dr. Kim received his MD degree from Seoul National University and his MBA from the University of Pennsylvania. He did his residency in internal medicine at the University of Arkansas, Little Rock followed by a fellowship in gastroenterology and advanced training in hematology/liver transplantation at Mayo Clinic.

Following his training, Ray joined the staff at Mayo Clinic and the faculty of the Mayo College of Medicine. He rose to the level of Professor of Medicine while building a leading clinical research group making seminal observations in liver transplantation, especially concerning public policy around organ allocation. His research has been funded through NIH for many years.

After completing her undergraduate degree from Yale University and M.D. from the University of Chicago, she pursued her residency and fellowship at the University of Pittsburgh.

As a physician scientist, Dr. Su has a long history of performing clinical and translational research in the area of chronic liver disease and cirrhosis. She is Director of the Morphomics Analysis Group at the University of Michigan, a multidisciplinary collaborative of physicians, biostatisticians and engineers developing methods for analyzing medical imaging. Their work has evolved into analytic morphomics, an innovative high-throughput, highly automated, anatomically indexed platform that measures body composition and organ condition. By linking imaging features to clinical outcomes, they have been able develop highly accurate non-invasive methods for the diagnosis and prognosis of patients with liver disease as well as hepatocellular carcinoma (HCC).

He has a longstanding interest and expertise in nonalcoholic fatty liver disease and conducted basic research focusing on the vascular changes in steatosis and their contribution to disease progression. His research unit continues to study pathophysiological mechanisms of NASH. He also conducts clinical research, and his unit is a partner in several research consortia supported by the European Commission. He and his unit participate in most of the clinical trials in the field, and he is a scientific committee member involved in the design of several phase 2 and one of the current phase 3 trials in NAFLD. He is a senior clinical researcher for the Research Fund of the Flemish government. He is board member of several scientific societies and currently also scientific coordinator of the Belgian week of Gastroenterology. Prof. Dr. Francque obtained his MD at the University of Antwerp, Belgium, in 1994 and was subsequently trained in internal medicine and in gastroenterology and hepatology at the Antwerp University Hospital, Belgium and at the Department of Hepatology of the Beaujon hospital, Clichy, France.

After her clinical training at hospital Sant Pau in Barcelona, she spent three years as a postdoctoral fellow at the Mount Sinai School of Medicine in New York and one year at IDIBAPS in Barcelona. In 2013, she joined the Hepatic Hemodynamic Unit at Hospital Clinic where she is fully dedicated to the management of patients with portal hypertension and vascular liver diseases as well as conducting liver catheterization procedures including TIPS. She also runs a translational laboratory focused on the understanding of the role of the liver endothelium in liver diseases.

She is recipient of the Rising Star in Gastroenterology prize by the UEG and the EASL Young Investigator Award. She is vice secretary of VALDIG, faculty of Baveno and associate editor of Liver International.